Effect of Rifampicin on the Pharmacokinetics of Apatinib in Chinese Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 02 Oct 2017
At a glance
- Drugs Apatinib (Primary) ; Rifampicin
- Indications Breast cancer; Colorectal cancer; Gastric cancer; Liver cancer; Non-small cell lung cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Jiangsu Hengrui Medicine Co.
- 02 Oct 2017 Results published in the Journal of Clinical Pharmacology
- 23 Feb 2017 Status changed from recruiting to completed.
- 21 Jul 2016 New trial record